Inactive Instrument

Intercell AG Stock

Equities

Duration

Period

Style

Intercell AG : Annual Report 2011	12-04-16	PU
Intercell AG : Intercell and Statens Serum Institut (SSI) progress vaccine clinical development to fight Tuberculosis	12-01-11	PU
Intercell AG : Thomas Szucs elected new chairman of Intercell’s Supervisory Board	11-12-30	PU
Intercell AG : Intercell and Biological E. Ltd. announce approval for Japanese Encephalitis vaccine in India	11-11-10	PU
Intercell AG : announces Q3 2011 results and provides an update on ongoing operations	11-11-08	PU

VIVALIS : et Intercell fusionnent pour former Valneva	12-12-17
Intercell AG : La biotech française Vivalis rachète l'autrichienne Intercell	12-12-17
Un vaccin expérimental contre l'hépatite C développé en France	11-08-03
INTERCELL ORD INTERCELL AG ORD SHS : Intercell : la dégringolade	11-05-24

Sector

	1st Jan change	Capi.
CSL LIMITED	-4.17%	86.99B
SAMSUNG BIOLOGICS CO.,LTD.	+4.34%	40.68B
BIOGEN INC.	-23.95%	28.61B
UCB	+50.44%	24.1B
BIOMARIN PHARMACEUTICAL INC.	-5.09%	17.37B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-32.11%	13.72B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-5.10%	12.49B
INCYTE CORPORATION	-14.91%	12B
SWEDISH ORPHAN BIOVITRUM AB	-3.07%	7.94B